PROKIDNEY CORP
(NASDAQ: PROK)
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease (CKD), shifting the emphasis away from management of kidney failure, to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells (SRCs) prepared from a patient's own, autologous, renal cells. The company is headquartered in Winston-Salem, NC.
3.910
-0.210
(-5.10%)
Range
3.630 - 4.330
(19.28%)
Open
-
Previous Close
4.120
Bid Price
10.640
Bid Volume
10
Ask Price
10.730
Ask Volume
8
Volume
1,433,917
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis